Cargando…

Influenza vaccination adherence after liver transplantation: A collateral benefit of the COVID-19 pandemic (results of a patients’ survey)

Detalles Bibliográficos
Autores principales:	Dumortier, Jérôme, Dharancy, Sébastien, Bréard, Thomas, Sérée, Olivier, Saliba, Faouzi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645288/ https://www.ncbi.nlm.nih.gov/pubmed/34583065 http://dx.doi.org/10.1016/j.clinre.2021.101815

Ejemplares similares

Influenza and SARS-CoV-2 vaccinations adherence after liver transplantation during the second year of the COVID-19 pandemic (results of a patients’ survey)
por: Dumortier, Jérôme, et al.
Publicado: (2022)

Five‐year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE study
por: Saliba, Faouzi, et al.
Publicado: (2022)

Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 Years
por: Saliba, Faouzi, et al.
Publicado: (2019)

How to Optimize the Results of Liver Transplantation for Acute-on-Chronic Liver Failure
por: Sacleux, Sophie-Caroline, et al.
Publicado: (2023)

Covid-19 in liver transplant recipients: the French SOT COVID registry
por: Dumortier, Jérôme, et al.
Publicado: (2021)

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis
por: Villeret, François, et al.
Publicado: (2023)

Liver Transplantation for Hepatocellular Carcinoma: A Real-Life Comparison of Milan Criteria and AFP Model
por: Brusset, Bleuenn, et al.
Publicado: (2021)

Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival
por: Villeret, François, et al.
Publicado: (2022)

Liver injury after mRNA-based SARS-CoV-2 vaccination in a liver transplant recipient
por: Dumortier, Jérôme
Publicado: (2022)

Collateral Benefit of COVID-19 Control Measures on Influenza Activity, Taiwan
por: Kuo, Shu-Chen, et al.
Publicado: (2020)

Antineoplastic chemotherapy and immunosuppression in liver transplant recipients: Squaring the circle?
por: Coupier, Antoine, et al.
Publicado: (2022)

Impact of the COVID-19 pandemic on liver transplant waitlist outcome in France
por: Legeai, Camille, et al.
Publicado: (2023)

Acquired diaphragmatic hernia after hepatectomy and liver transplantation in adults and children: A case series and literature review
por: Martin, Valentine, et al.
Publicado: (2021)

Primary sarcoma of the liver and transplantation: a case study and literature review
por: Bismuth, Benjamin, et al.
Publicado: (2009)

Cytomegalovirus Management in Solid Organ Transplant Recipients: A Pre-COVID-19 Survey From the Working Group of the European Society for Organ Transplantation
por: Grossi, Paolo Antonio, et al.
Publicado: (2022)

Collateral benefits of studying the vagus nerve in bioelectronic medicine
por: Pavlov, Valentin A.
Publicado: (2019)

Collateral benefits: Unintended consequences of the Roots of Empathy program
por: Fransoo, Randy, et al.
Publicado: (2017)

The Features of Extrahepatic Collateral Arteries Related to Hepatic Artery Occlusion and Benefits in the Transarterial Management of Liver Tumors
por: Yang, Lin, et al.
Publicado: (2013)

Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence from an International Randomized Trial of Everolimus-Based Immunosuppression
por: Saliba, Faouzi, et al.
Publicado: (2018)

Neo-Adjuvant Use of Sorafenib for Hepatocellular Carcinoma Awaiting Liver Transplantation
por: Minoux, Kate, et al.
Publicado: (2022)

Mycophenolate mofetil decreases humoral responses to three doses of SARS‐CoV‐2 vaccine in liver transplant recipients
por: Meunier, Lucy, et al.
Publicado: (2022)

Quality of life 10 years after liver transplantation: The impact of graft histology
por: Karam, Vincent, et al.
Publicado: (2016)

Outcome of patients treated with molecular adsorbent recirculating system albumin dialysis: A national multicenter study
por: Camus, Christophe, et al.
Publicado: (2020)

Re: Association Between Renal Dysfunction and Major Adverse Cardiac Events After Liver Transplantation: Evidence From an International Randomized Trial of Everolimus-Based Immunosuppression
por: Saliba, Faouzi, et al.
Publicado: (2019)

New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

Erratum to: New Directions for Rabbit Antithymocyte Globulin (Thymoglobulin(®)) in Solid Organ Transplants, Stem Cell Transplants and Autoimmunity
por: Mohty, Mohamad, et al.
Publicado: (2014)

A Multicenter, Prospective, Observational Study of Conversion from Twice-Daily Immediate-Release to Once-Daily Prolonged-Release Tacrolimus in Liver Transplant Recipients in France: The COBALT Study
por: Dumortier, Jérôme, et al.
Publicado: (2019)

Adherence and Treatment Satisfaction in Liver Transplant Recipients
por: Albekairy, Abdulkareem M., et al.
Publicado: (2016)

Collateral benefits of Internet use: Explaining the diverse outcomes of engaging with the Internet
por: Van Deursen, Alexander JAM, et al.
Publicado: (2017)

Collateral benefits on other respiratory infections during fighting COVID-19
por: Chan, Khee-Siang, et al.
Publicado: (2020)

Collateral benefits on other respiratory infections during fighting COVID-19
por: Chan, Khee-Siang, et al.
Publicado: (2020)

Survival Benefit of Living-Donor Liver Transplant
por: Jackson, Whitney E., et al.
Publicado: (2022)

Development of Collaterals in Intermittent and Permanent Ischemia of the Liver
por: Ok, Engin, et al.
Publicado: (1996)

Systemic Viral Infections and Collateral Damage in the Liver
por: Adams, David H., et al.
Publicado: (2006)

The Molecular Adsorbent Recirculating System (MARS(®)) in the intensive care unit: a rescue therapy for patients with hepatic failure
por: Saliba, Faouzi
Publicado: (2006)

Impact of DSA and immunosuppression minimization on rejection, graft, and patient survival after simultaneous liver–kidney transplantation
por: Dekeyser, Manon, et al.
Publicado: (2022)

Evidence for Alloimmune Sinusoidal Injury in De Novo Nodular Regenerative Hyperplasia After Liver Transplantation
por: Sebagh, Mylène, et al.
Publicado: (2023)

Combined Liver-Kidney Transplantation With Preformed Anti–human Leukocyte Antigen Donor-Specific Antibodies
por: Del Bello, Arnaud, et al.
Publicado: (2020)

Benefits of tailored hepatocellular carcinoma screening in patients with cirrhosis on cancer‐specific and overall mortality: A modeling approach
por: Ningarhari, Massih, et al.
Publicado: (2022)

Integrating an addiction team into the management of patients transplanted for alcohol-associated liver disease reduces the risk of severe relapse
por: Daniel, Jules, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_vt2kiqjbcgu3jnmapm6b8kdke6